Back to today’s briefing

Story perspectives

FDA Urged to Combat Illegal Sales of Life-Changing Obesity Drug

2/21/2025

25 3

Summary

Story summary

Eli Lilly's groundbreaking obesity drug, retatrutide, is transforming lives, with some trial participants shedding over 30% of their weight. While it offers hope for better health, many face side effects like nausea. In response to soaring demand and supply shortages, state attorneys general are calling on the FDA to crack down on illegal sales of these vital medications.

1 of 1

Story summary

Eli Lilly's groundbreaking obesity drug, retatrutide, is transforming lives, with some trial participants shedding over 30% of their weight. While it offers hope for better health, many face side effects like nausea. In response to soaring demand and supply shortages, state attorneys general are calling on the FDA to crack down on illegal sales of these vital medications.